Xylazine (or “tranq”) is a non-opioid sedative and tranquilizer only approved for use in veterinary medicine. However, over the past several years, human consumption of xylazine has begun rapidly increasing. […]
The purpose of this presentation is to review the neurobiology of substance use disorders and how medications can effectively improve outcomes in SUD treatment by disrupting the cycle of addiction […]
Family treatment courts (FTCs) have improved safety, permanency, well-being, and recovery outcomes for families in the child welfare system associated with parental substance use for over 25 years. Despite these […]